More articles from General Clinical Specialties: Endocrinology

You have access
Is FDG PET valuable in the management of pulmonary metastases from differentiated thyroid cancer? A comparative study with radioiodine scan and MDCT
Kunihiro Nakada, Masayuki Tsujisaki, Yuya Onodera and Hiroki Shirato

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 273P;
You have access
Difference in significance of FDG accumulating lesions according to the location in thyroidectomized patients with differentiated thyroid cancer
JH Seo, Seong Min Kang, Jin Ho Bae, Sang Woo Lee, Byeong Chul Ahn and Jaetae Lee

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 266P;
You have access
Exhalation of I-131 after radioiodine therapy: Dependence on radioactivity applied
Thomas Fischer, Sebastian Weber, Mark Gaidouk, Daniela Kittel, Markus Dietlein, Harald Schicha and Klaus Schomaecker

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 268P;
You have access
Development of E-Learning system for education of thyroid patients scheduled for radioactive iodine
Kyung Hoon Hwang, Duck-Joo Choi, Hyung-Ji Lee and Wonsick Choe

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 266P;
You have access
Thyroglobulin before ablative radioiodine therapy as an early indicator of metastasis or recurrence in differentiated thyroid carcinoma
Samer Ezziddin, Frank Grünwald, Anja Morgner, Kim Biermann, Hojjat Ahmadzadehfar, Jan Bucerius and Hans-Jürgen Biersack

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 276P;
You have access
Percutaneous ethanol injection in the management of bone metastasis from thyroid cancer
Kunihiro Nakada, Masayuki Tsujisaki, Hiroki Shirato and Kazuo Miyasaka

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 267P;
You have access
Serum thyrotrophic-receptor auto antibodies levels after 131I therapy in Graves’ patients and effect of pretreatment with ATD
Liu Jianzhong and An Caixia

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 274P;
You have access
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman and Leonard Wartofsky

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 268P;
You have access
Usefulness of anti-thyroglobulin antibody as tumor marker after total thyroidectomy and radioiodine ablation therapy in papillary carcinoma patients
Won Hyoung Lee, Ie Ryung Yoo, Sung Hoon Kim, Hyung Sun Sohn and Soo Kyo Chung

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 272P;
You have access
The utility of the interpretation of PET-MR simultaneously versus independently of each other in patients with well-differentiated thyroid cancer
Elmo Acio, Alexander Mark, Douglas Van Nostrand, Shari Moreau, Laura Seiboth and Kennth Burman

Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 269P;

Main menu

User menu

Search

More articles from General Clinical Specialties: Endocrinology

Pages